Answers are grounded in this paper and cite their sources.
Demonstrates that endothelial GATA4 deletion triggers liver fibrosis via MYC and PDGFB signaling, identifying downstream pathways as potential therapeutic targets.
The liver vasculature is supposed to play a major role in the development of liver fibrosis and cirrhosis, which can lead to liver failure and liver cancer. Herein, we discovered that structural and transcriptional changes induced by genetic deletion of the transcription factor GATA4 in the hepatic endothelium were sufficient to cause liver fibrosis. Activation of the transcription factor MYC and de novo expression of the "angiocrine" growth factor PDGFB were identified as downstream drivers of fibrosis and as potential therapeutic targets for this potentially fatal disease.
No takes yet. Share an insight, caveat, or question.
Winkler et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: